- Report
- July 2024
- 150 Pages
Global
From €3259EUR$3,750USD£2,841GBP
- Report
- June 2024
- 200 Pages
Global
From €6908EUR$7,950USD£6,022GBP
- Report
- June 2023
- 200 Pages
Global
From €6517EUR$7,500USD£5,681GBP
- Report
- April 2023
- 240 Pages
Global
From €3041EUR$3,500USD£2,651GBP
- Report
- February 2024
- 110 Pages
Global
From €4128EUR$4,750USD£3,598GBP
- Report
- April 2023
- 115 Pages
Global
From €4128EUR$4,750USD£3,598GBP
- Report
- April 2023
- 160 Pages
Global
From €4300EUR$4,949USD£3,749GBP
- Report
- October 2024
- 140 Pages
Global
From €2172EUR$2,500USD£1,894GBP
- Report
- April 2023
- 116 Pages
Global
From €3910EUR$4,500USD£3,409GBP
- Report
- January 2025
- 105 Pages
Global
From €3500EUR$4,315USD£3,158GBP
- Report
- December 2024
- 70 Pages
Global
From €3471EUR$3,995USD£3,026GBP
- Report
- October 2022
- 81 Pages
Global
From €3037EUR$3,495USD£2,648GBP
- Report
- August 2024
- 133 Pages
China
From €1564EUR$1,800USD£1,364GBP
- Report
- August 2024
- 101 Pages
China
From €1564EUR$1,800USD£1,364GBP
- Report
- January 2024
- 109 Pages
United States
€3041EUR$3,500USD£2,651GBP
- Report
- February 2018
- 680 Pages
Global
From €19117EUR$22,000USD£16,665GBP
- Report
- October 2024
- 90 Pages
Global
From €3500EUR$4,315USD£3,158GBP
- Report
- October 2023
- 101 Pages
Global
From €3500EUR$4,315USD£3,158GBP
- Report
- August 2023
- 94 Pages
Global
From €3500EUR$4,315USD£3,158GBP
- Report
- May 2023
- 94 Pages
Global
From €3500EUR$4,315USD£3,158GBP

The Asthma Treatment market is composed of a variety of drugs used to treat asthma symptoms. These drugs are divided into two main categories: long-term control medications and quick-relief medications. Long-term control medications are taken daily to reduce inflammation and prevent asthma symptoms. Quick-relief medications are taken as needed to quickly relieve asthma symptoms. Common long-term control medications include inhaled corticosteroids, leukotriene modifiers, and long-acting beta-agonists. Common quick-relief medications include short-acting beta-agonists and anticholinergics.
The Asthma Treatment market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Novartis, Sanofi, and Teva Pharmaceuticals. Show Less Read more